Autologous human Schwann cells

BIOLOGICAL6 trials

Sponsors

W. Dalton Dietrich

Conditions

ParaplegiaPeripheral Nerve InjuriesQuadriplegiaSciatic Nerve InjurySpinal Cord InjuryTetraplegia

Phase 1

Safety of Autologous Human Schwann Cells (ahSC) in Subjects With Subacute SCI

CompletedNCT01739023

W. Dalton DietrichParaplegia, Spinal Cord Injury

Start: 2012-11-30End: 2016-08-31Updated: 2019-03-05

The Safety of ahSC in Chronic SCI With Rehabilitation

CompletedNCT02354625

W. Dalton DietrichParaplegia, Quadriplegia, Spinal Cord Injury +1

Start: 2015-01-31End: 2019-08-12Updated: 2019-08-14

Autologous Human Schwann Cells in Peripheral Nerve Repair

CompletedNCT03999424

W. Dalton DietrichPeripheral Nerve Injuries

Start: 2019-09-24End: 2025-12-04Updated: 2025-12-12

Unknown Phase

Expanded Access for Single Patient Treatment of Autologous Human Schwann Cells (ahSC) for Peripheral Nerve Repair

W. Dalton DietrichSciatic Nerve Injury

Updated: 2019-03-05

Emergent Expanded Access for ahSC Augmentation of Nerve Autografts After Severe Peripheral Nerve Injury.

W. Dalton DietrichSciatic Nerve Injury

Updated: 2021-11-16

Expanded Access - Autologous Human Schwann Cells in Peripheral Nerve Repair

W. Dalton DietrichPeripheral Nerve Injuries

Updated: 2020-07-10

Related Papers

Development and deployment of an at-home strength and conditioning program to support a phase I trial in persons with chronic spinal cord injury.

2020-06-039 citations